<DOC>
	<DOCNO>NCT02982915</DOCNO>
	<brief_summary>This phase I/II , randomize , blind placebo-controlled study test safety efficacy LMCSs improve vaccine immune response .</brief_summary>
	<brief_title>Human Mesenchymal Stem Cells ( LMSCs ) Vaccine-Specific Antibody- Response Subjects With Aging Frailty</brief_title>
	<detailed_description>A pilot phase consist 3 subject safety run-in , follow 20 subject randomize phase evaluate influenza vaccine response 1 week 4 week post infusion LMSCs . This follow double-blinded , randomize , placebo-controlled phase .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>willing able provide write informed consent comply procedure require protocol . 65 85 year age time sign Informed Consent Form . diagnosis Aging Frailty , score 4 7 use Canadian Frailty Scale . serum tumor necrosis factor level ( TNFα ) ≥ 2.5 pg/mL . sixminute walk test ( 6MWT ) distance 200m 400m 2 trial , 2 trial must within 15 % . total bilirubin 0.3 1.9 mg/dL . unwilling unable perform assessment require Protocol . score ≤24 Mini Mental State Examination ( MMSE ) . previously receive current year 's fluvaccine . contraindication receive vaccine . Hemoglobin A1c ( HbA1c ) level &gt; 8.0 % . diagnose malignancy ( subject without recurrence last 2.5 year allow ) except curativelytreated basal cell carcinoma , melanoma situ , cervical carcinoma . condition project limit lifeexpectancy ≤1 year . autoimmune disease ( e.g. , rheumatoid arthritis ) . use medication ( ) know alter immune response , e.g. , highdose corticosteroid . HIV , AIDS , immunodeficiency . test positive hepatitis B HsAg , verimic hepatitis C , HIV1 , HIV2 , syphilis . rest blood oxygen saturation &lt; 93 % ( measure pulse oximetry ) . female pregnant , nursing , childbearing potential practicing effective contraception . document current substance and/or alcohol abuse . know allergy latex egg . know hypersensitivity dimethyl sulfoxide ( DMSO ) . organ transplant recipient ( corneal transplant ) . actively list ( expect list ) transplant organ ( corneal transplant ) . clinically important abnormal screen laboratory value , include limited : hemoglobin &lt; 10.0 g/dL . white blood cell count &lt; 2500/mm3 . platelet &lt; 100,000/mm3 . prothrombin time/international normalize ratio ( PT/INR ) ˃ 1.5 due reversible cause ( i.e . Coumadin ) . aspartate transaminase , alanine transaminase , alkaline phosphatase ˃ 2 time upper limit normal . sit rest systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 110 mm Hg Screening . serious illness condition , opinion investigator , may compromise safety compliance subject preclude successful completion study , may compromise validity study . currently participate investigational therapeutic device trial , participate investigational therapeutic device trial within previous 30 day , participate clinical trial duration time subject actively participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>